Psychopharmacology. FDA weighs suicide risk in children on antidepressants

Science. 2004 Feb 6;303(5659):745. doi: 10.1126/science.303.5659.745a.
No abstract available

Publication types

  • News

MeSH terms

  • Adolescent
  • Advisory Committees
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Anxiety Disorders / drug therapy
  • Child
  • Controlled Clinical Trials as Topic
  • Depressive Disorder / drug therapy
  • Humans
  • Product Surveillance, Postmarketing
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Suicide*
  • United Kingdom
  • United States
  • United States Food and Drug Administration*

Substances

  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors